< Return to Virtual Testing Guide

ANA Screen, IFA, Reflex Titer/Pattern, and Reflex to Multiplex 11 Ab Cascade

Test Code: 16814

Methodology: Immunofluorescent Assay (IFA)

Clinical Significance: Antinuclear antibodies are associated with rheumatic diseases including Systemic Lupus Erythematous (SLE), mixed connective tissue disease, Sjogren's syndrome, scleroderma, polymyositis, CREST syndrome, and neurologic SLE.

Includes: The ANA Screen, IFA, Reflex Titer/Pattern, and Reflex to Multiplex 11 Ab Cascade begins with an ANA Screen, IFA.

< Return to Virtual Testing Guide

C-reactive Protein

Test Code: 4420

Methodology: Nephelometry

Limitations: Oral contraceptives, IUDs, pregnancy, and menstruation may raise CRP levels. Levels are lowest during ovulation.

Clinical Significance: Increased CRP levels are found in inflammatory conditions including: bacterial infection, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state. This test cannot detect the relatively small elevations of CRP that are associated with increased cardiovascular risk.

< Return to Virtual Testing Guide

Rickettsia (RMSF) Antibodies (IgG, IgM) with Reflex to Titers

Test Code: 6419

Includes: If Rickettsia (RMSF) Antibodies (IgG, IgM) is Detected, the appropriate Titer will be performed at an additional charge.

Methodology: Immunofluorescent Assay (IFA)

Limitations: Even after infection has been treated, positive results may persist. False-positive reactions may occur during pregnancy.

< Return to Virtual Testing Guide

Lyme Disease Antibody w/ Reflex to Blot (IgG, IgM)

Test Code: 6646

Includes: If Lyme Disease Antibody Screen is Equivocal or Positive, Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge.

Methodology: Immunoassay (IA)

< Return to Virtual Testing Guide

Rubella Testing

Test Code:
Rubella Immune Status: 802
Rubella Antibodies (IgG, IgM) Diagnostic: 37673
Rubella Antibodies IgM: 4422
Rubella Premarital: 5780

Methodology:
Rubella Immune Status: Immunoassay (IA)
Rubella Antibodies (IgG, IgM) Diagnostic: Immunoassay (IA)
Rubella Antibodies IgM: Immunoassay (IA)
Rubella Premarital: Enzyme Immunoassay (EIA)

< Return to Virtual Testing Guide

Rubella Immune Status

Test Code: 802

Methodology: Immunoassay (IA)

Clinical Significance: Rubella is an acute exanthematous viral infection of children and adults. Rash, fever and lymphadenopathy characterize the illness. While many infections are subclinical, this virus has the potential to cause fetal infection with resultant birth defects. Diagnosis of a Rubella infection is best made serologically. In the absence of a current or recent infection, a demonstration of specific IgG on a serum sample is evidence of immunity to Rubella.

< Return to Virtual Testing Guide

Mumps Antibody Panel, IFA (CSF)

Test code: 18970RXE

Methodology: Immunofluorescence Assay
FDA Status - ASR1
This test was developed and its analytical performance characteristics have been determined by Focus Diagnostics, San Juan Capistrano, CA. It has not been cleared or approved by the U.S. Food and Drug Administration. The FSA has deteremined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Includes: Mumps IgG, IgM

 

< Return to Virtual Testing Guide

Mumps Virus Antibody Testing (Serum)

Test Code:
Mumps Virus IgG: 8624
Mumps Virus IgM: 36565
Mumps Virus IgG, IgM: 36564

Supply: 53712 Red Top Tube (NO GEL) 10mL

Includes:
Test code 8624: Mumps Virus IgG
Test code 36565: Mumps Virus IgM
Test code 36564: Mumps Virus IgG, IgM

Methodology:
Mumps Virus IgG: Immunoassay (IA)
Mumps Virus IgM: Immunofluorescence Assay (IFA)
Mumps Virus IgG, IgM: Immunoassay (IA) and Immunofluorescence (IFA)

Pages